Michael Harrington to Neoadjuvant Therapy
This is a "connection" page, showing publications Michael Harrington has written about Neoadjuvant Therapy.
Connection Strength
0.346
-
Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial. J Immunother Cancer. 2026 Jan 14; 14(1).
Score: 0.234
-
The impact of neoadjuvant hedgehog inhibitor therapy on the surgical treatment of extensive basal cell carcinoma. Ann Plast Surg. 2015 Jun; 74 Suppl 4:S193-7.
Score: 0.112